To investigate the clinical relevance of EGFR, EpCAM, TF, and TROP2 expression, we stratified TNBC tissue samples by tumor stage (I–III), histological grade (G1–G3), and patient age and assessed marker distribution via mIF analysis. This evidence concerns the gene TACSTD2 and neoplasm.